Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Microfluidic cell culture of patient-derived tumor cell spheroids

Microfluidic cell culture of patient-derived tumor cell spheroids

US Patent 10472599 · Granted Nov 12, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic targeting of KMT2D mutant lung squamous cell carcinoma through RTK-R2025
Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture d2024
Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture d2024
Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture d2024
Combination therapy for treatment of LKB1 deficient cancers2024
STING levels as a biomarker for cancer immunotherapy2024
STING levels as a biomarker for cancer immunotherapy2024
Compositions and methods of modulating anti-tumor immunity2024
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint in2023
Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture d2023
Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture d2023
Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture d2023